ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Haolin Song
Matched on ORCID iD 0009-0004-0245-9744; OpenAlex author ID A5039727332. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers
Papers 7
- Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal aden… Co-author DOI 10.1016/j.biomaterials.2025.123630↗
- Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2026.124406↗
- Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Co-author DOI 10.1002/advs.202507118↗
- Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy. Co-author DOI 10.1021/acs.nanolett.4c06372↗
- Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment. Co-author DOI 10.1016/j.actbio.2023.05.047↗
- Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2022.121599↗
- Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/17425247.2022.2045943↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chen Jiang · 7 shared papers, 2022–2026 · strength 1.60
- Paper Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1080/17425247.2022.2045943↗
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Hongrui Fan · 5 shared papers, 2023–2026 · strength 1.14
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Yu Wang · 4 shared papers, 2022–2026 · strength 0.86
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Tao Sun · 4 shared papers, 2022–2026 · strength 0.76
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Qinjun Chen · 3 shared papers, 2023–2026 · strength 0.64
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Shilin Zhang · 3 shared papers, 2023–2026 · strength 0.61
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Hongyi Chen · 3 shared papers, 2022–2025 · strength 0.50
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Paper Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvi… DOI 10.1016/j.biomaterials.2022.121599↗
- Chufeng Li · 3 shared papers, 2022–2025 · strength 0.50
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Paper Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvi… DOI 10.1016/j.biomaterials.2022.121599↗
- Yifan Luo · 2 shared papers, 2022–2023 · strength 0.26
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Paper Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvi… DOI 10.1016/j.biomaterials.2022.121599↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.